Hot topics close

Two more blood pressure drugs recalled for potential cancer risk

photo

- Teva Pharmaceuticals announced that they've launched a voluntary recall into two drugs used to treat high blood pressure as more medications face concerns over a possible cancer risk.

Teva said in a statement released by the Food and Drug Administration, the recall impacts all lots of combination tablets featuring the drugs amlodipine and valsartan and another combo drug featuring amlodipine, valsartan, and hydrochlorothiazide.

According to the FDA, the drugs could contain an impurity called N-nitroso-diethylamine, which has been classified as a possible human carcinogen.

Those taking either drugs should contact their doctor or pharmacist for advice or alternative treatments. Stopping the drugs immediately with no comparable alternative could pose a greater risk to patients' health, Teva explained.

Similar shots
  • Doctors: Blood pressure drug substitutes are available for patients affected by recalls
  • Two more blood pressure drugs recalled for potential cancer risk
  • More blood pressure pills recalled for cancer concerns
  • List of amlodipine and valsartan blood pressure drugs under recall added November 2018: Mylan, Teva Pharmaceuticals
This week's most popular shots